• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Finland·Consumer Cyclical·REMEDY.HE
Share

Remedy Entertainment Oyj Stocks

€ 18.58Last Updated 31.08.2026

Issuer Rating

3/7
Performance

Modest

Risk

Considerable

Recommendation

Sell

Market Cap

€ 296.38M

€ 18.58
Key Takeaways

Risk factor

Very poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly overvalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Latest news

09.01.2026 09:01

How to make money on small caps in the gaming sector

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Remedy Entertainment Oyj is a Finnish developer and publisher of video games for PC and console platforms. Established in 1995, the company operates globally from its headquarters in Espoo, Finland. It is particularly renowned for crafting action-packed titles that feature compelling narratives and striking visual design.

Company Valuation

Greatly overvalued
1/7

Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers. In particular, the stock is overpriced on P/E, 'expensive' on EV/EBITDA

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Neutral
4/7

The average target price of REMEDY.HE is 20.1 and suggests 8.18% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommen

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

02.09.2026 13:57

Dell raised its annual revenue forecast by $25 billion. Its stock soared.

02.09.2026 12:23

BP Appoints New Chairman of the Board of Directors Following a High-Profile Dismissal

02.09.2026 11:25

AI Is Displacing the Auto Industry: Nokia Will Return to Europe's "Blue-Chip" Index in Place of VW

02.09.2026 10:58

Top Stories This Morning: OpenAI to Restrict Access to the Astra Model; U.S. and Iran Exchange Strikes

02.09.2026 09:00

A Fed official said he would support a rate hike if inflation does not slow down

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026